Despite the low clinical suspicion of a myeloproliferative disorder, due to normal blood counts and associated HCV cirrhosis, screening for MPN drivers was employed and identified a type 1 CALR mutation. The gene discussed is CALR; the disease is myeloproliferative disorder.